EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access

Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery

Jai Jai Shiva Shankar, Susan Alcock, Nima Kashani, Tim Darsaut, Bill Hao Wang, Marlise P Dos Santos, Geneviève Milot, Cian O'Kelly, Michael E Kelly, Daniela Iancu, Adela Cora, Tom Marotta und 22 weitere

JAMA · 26.05.2026 · 335 (20) · 1787

DOI: 10.1001/jama.2026.4910 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA, erschienen am 26.05.2026. Verfasst von Jai Jai Shiva Shankar und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Manitoba, Winnipeg, Canada. Hauptthemen laut MEDLINE: Drainage, Embolization, Therapeutic, Hematoma, Subdural, Chronic, Meningeal Arteries. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Chronic subdural hematomas commonly recur after surgical drainage. The effect of adjunctive embolization of the middle meningeal artery (EMMA) on recurrence risk remains unclear.

Objective

To evaluate whether EMMA as an adjunct to surgical drainage reduces chronic subdural hematoma recurrence compared with surgery alone. Design, Setting, and Participants This trial was a randomized, open-label, blinded–end point trial involving adults with unilateral, symptomatic chronic subdural hematoma (≥10 mm) undergoing surgical drainage across 9 tertiary care centers in Canada between August 2021 and April 2025.

Intervention

EMMA using a liquid embolic agent (Onyx-18) within 72 hours after surgical drainage vs a control group that did not receive EMMA after surgical drainage. Main Outcomes and Measures Primary outcome was symptomatic recurrence of chronic subdural hematoma detected on computed tomographic (CT) scan at 90 days (range, 60 to 120 days). Secondary outcomes included radiographic recurrence of chronic subdural hematoma, 90-day mortality, and serious adverse events. The last date of follow-up was July 27, 2025.

Results

Of 192 randomized participants, 186 (mean age, 71.8 years; 136 male [73%]) completed the trial (93 per group). The primary outcome of symptomatic recurrence of chronic subdural hematoma detected on CT scan occurred in 4 participants (4.3%) in the EMMA group vs 26 patients (28%) in the control group (risk difference, −23.7; 95% CI, −34.1 to −13.9; P < .001). Radiographic recurrence occurred in 13 participants (14%) in the EMMA group vs 46 patients (49.5%) in the control group. Mortality was 4.3% vs 1.1%; serious adverse events occurred in 8.6% vs 5.4%, respectively. Conclusions and Relevance Adjunctive EMMA after surgical drainage significantly reduced symptomatic recurrence on CT scan of unilateral chronic subdural hematoma at 90 days compared with surgery alone. Trial Registration ClinicalTrials.gov Identifier: NCT04750200

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DrainageEmbolization, TherapeuticHematoma, Subdural, ChronicMeningeal ArteriesAgedAged, 80 and overFemaleHumansMaleMiddle AgedCombined Modality TherapyRecurrenceTomography, X-Ray ComputedPolyvinylsTantalumFollow-Up StudiesTreatment OutcomeDrug Combinations

Substanzen

Onyx 18PolyvinylsTantalumDrug Combinations

Autor:innen und Institutionen

  • Department of Radiology, University of Manitoba, Winnipeg, Canada.
  • Department of Human Anatomy and Cell Sciences, University of Manitoba, Winnipeg, Canada.
  • Department of Biomedical Engineering, Price Faculty of Engineering, University of Manitoba, Winnipeg, Canada.
  • Section of Neurosurgery, Department of Surgery, University of Alberta, Edmonton, Canada.
  • Section of Neurosurgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
  • Department of Radiology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Zitieren

APA

Shankar, J. J. S., Alcock, S., Kashani, N., Darsaut, T., Wang, B. H., Dos Santos, M. P., Milot, G., O'Kelly, C., Kelly, M. E., Iancu, D., Cora, A., Marotta, T., van Adel, B., Kishore, K., Drake, B., Lesiuk, H., Carrondo-Cottin, S., Rempel, J., Ahmed, U., …, & EMMA-Can investigators (2026). Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery. JAMA, 335(20), 1787. https://doi.org/10.1001/jama.2026.4910

Vancouver

Shankar JJS, Alcock S, Kashani N, Darsaut T, Wang BH, Dos Santos MP, et al. Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery. JAMA. 2026;335(20):1787. doi:10.1001/jama.2026.4910

BibTeX
@article{Shankar2026,
  author = {Shankar, Jai Jai Shiva and Alcock, Susan and Kashani, Nima and Darsaut, Tim and Wang, Bill Hao and Dos Santos, Marlise P and Milot, Geneviève and O'Kelly, Cian and Kelly, Michael E and Iancu, Daniela and Cora, Adela and Marotta, Tom and van Adel, Brian and Kishore, Kislay and Drake, Brian and Lesiuk, Howard and Carrondo-Cottin, Sylvine and Rempel, Jeremy and Ahmed, Uzair and Chaalala, Chiraz and Silvaggio, Joseph and Kaderali, Zul and McEachern, James and Salam, Mohammed Suheel Abdul and Sinha, Namita and Marin, Roman and Leung, Yan Sin and Balshaw, Robert and Fleetwood, Ian and Jiang, Depeng and Menon, Bijoy K and Singh, Nishita and Zeiler, Frederick A and EMMA-Can investigators, EMMA-Can investigators},
  title = {Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {20},
  pages = {1787},
  doi = {10.1001/jama.2026.4910}
}
Kostenlos starten →